Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)

NCT06013865 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT06013865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06013865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Investigation of the Safety of Empagliflozin in Kidney Transplant Recipients (SEKTR)
Lead sponsor
VA Office of Research and Development
Phase
Phase 4
Overall status
Recruiting
Start date
April 5, 2024
Completion date
March 31, 2030
Enrollment
264 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, kidney transplant